Antidepressant Withdrawal: A Clinician’s Middle View
Mad in America
OCTOBER 31, 2023
Pharmaceutical companies, exerting their influence on academic psychiatry through lucrative honoraria and advisory board payments, have clearly played a role in how antidepressant risks have been presented. This notable gap has raised some suspicion that the necessary research has not merely been overlooked but deliberately avoided.
123 
Let's personalize your content